Challenges in Brain Death Determination and Apnea Testing for Patients with COVID-19.
J Stroke Cerebrovasc Dis
; 29(12): 105419, 2020 Dec.
Article
em En
| MEDLINE
| ID: mdl-33254379
ABSTRACT
INTRODUCTION:
Apnea testing remains essential for the clinical evaluation of brain death determination. In patients who test positive for SARS-CoV-2, disconnecting the patient from the ventilator and introducing high flow oxygen into the endotracheal tube increases the risk for aerosolization of airway secretions and exposure of the examiner.METHODS:
Case report of a patient with an intracerebral hemorrhage that evolved to significant cerebral edema and herniation, who underwent apnea test using a method involving a t-piece and an HME filter.RESULTS:
Patient successfully pronounced brain dead using a safe method to minimize exposure to SARS-CoV-2.CONCLUSION:
At a time where healthcare workers are at high risk of exposure to COVID-19, the above described method is a safe process for apnea testing in declaration of brain death.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Apneia
/
Morte Encefálica
/
Edema Encefálico
/
Hemorragia Cerebral
/
Saúde Ocupacional
/
Transmissão de Doença Infecciosa do Paciente para o Profissional
/
Encefalocele
/
COVID-19
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article